{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:15:15Z","timestamp":1761488115615},"reference-count":40,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.vaccine.2008.08.059","type":"journal-article","created":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T11:53:27Z","timestamp":1221652407000},"page":"5952-5956","source":"Crossref","is-referenced-by-count":8,"title":["Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: Implications for introducing PorA based vaccines"],"prefix":"10.1016","volume":"26","author":[{"given":"David","family":"Pace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Cuschieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Galea Debono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Attard-Montalto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2008.08.059_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00006454-200004000-00015","article-title":"Vaccines for prevention of meningococcal disease","volume":"19","author":"Pollard","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.08.059_bib2","unstructured":"Environmental Science and Research Limited. The Epidemiology of Meningococcal Disease in New Zealand in 2006. Wellington: Ministry of Health; 2006. Available from http:\/\/www.moh.govt.nz\/moh.nsf\/pagesmh\/6647\/$File\/epidemiology-of-meningococcal-disease-2006.pdf."},{"issue":"May (18)","key":"10.1016\/j.vaccine.2008.08.059_bib3","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2008.08.059_bib4","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"issue":"May (RR-7)","key":"10.1016\/j.vaccine.2008.08.059_bib5","first-page":"1","article-title":"National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2008.08.059_bib6","unstructured":"Meningitis Research Foundation of Canada. Vaccines. Available from http:\/\/www.meningitis.ca\/vaccines\/meningococcal.asp."},{"issue":"8346","key":"10.1016\/j.vaccine.2008.08.059_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2008.08.059_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1099\/00222615-12-1-107","article-title":"Development of antibodies to meningococcal protein and lipopolysaccharide serotype antigens in healthy-carriers","volume":"12","author":"Jones","year":"1979","journal-title":"J Med Microbiol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2008.08.059_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/infdis\/150.1.71","article-title":"Immune response of infants and children to disseminated infections with Neisseria meningitidis","volume":"150","author":"Griffiss","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.08.059_bib10","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/IAI.59.9.2963-2971.1991","article-title":"Topology of outer membrane porins in pathogenic Neisseria spp.","volume":"59","author":"Van der Ley","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.08.059_bib11","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/S0264-410X(03)00033-1","article-title":"Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?","volume":"21","author":"Clarke","year":"2003","journal-title":"Vaccine"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2008.08.059_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1099\/00222615-43-5-335","article-title":"Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease","volume":"43","author":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"1995","journal-title":"J Med Microbiol"},{"issue":"January (7\u20138)","key":"10.1016\/j.vaccine.2008.08.059_bib13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0264-410X(02)00591-1","article-title":"Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease","volume":"21","author":"Holst","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.059_bib14","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/IAI.64.7.2745-2751.1996","article-title":"Specificity of human bactericidal antibodies against PorA P1.7, 16 induced with a hexavalent meningococcal outer membrane vesicle vaccine","volume":"64","author":"Rouppe van der Voort","year":"1996","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.059_bib15","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2008.08.059_bib16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo Brazil","volume":"340","author":"De Moraes","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.08.059_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0950268800047713","article-title":"Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile","volume":"105","author":"Cruz","year":"1990","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.08.059_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"November (8775)","key":"10.1016\/j.vaccine.2008.08.059_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"Suppl. 12","key":"10.1016\/j.vaccine.2008.08.059_bib20","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1097\/01.inf.0000147645.53942.00","article-title":"The strategy to control New Zealand\u2019s epidemic of group B meningococcal disease","volume":"23","author":"O\u2019Hallahan","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"July (10)","key":"10.1016\/j.vaccine.2008.08.059_bib21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2008.08.059_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0264-410X(95)98264-B","article-title":"Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine","volume":"13","author":"Van der Ley","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.059_bib23","unstructured":"Census of Population and Housing 2005, Population, vol. 1. Valletta: National Statistics Office; 2007. Available from http:\/\/www.nso.gov.mt\/docs\/Census2005_Vol1.pdf."},{"key":"10.1016\/j.vaccine.2008.08.059_bib24","unstructured":"EU-IBIS Network. Invasive Neisseria meningitidis in Europe 2003\/2004. London: Health Protection Agency; 2006. Available from www.euibis.org."},{"key":"10.1016\/j.vaccine.2008.08.059_bib25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(85)90812-8","article-title":"Meningococcal disease and season in sub-Saharan Africa","volume":"2","author":"Greenwood","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.08.059_bib26","unstructured":"World Health Organisation. Control of Epidemic Meningococcal Disease: WHO Practical Guidelines. 2nd ed. Geneva, Switzerland: World Health Organisation; 1998. Available from http:\/\/www.who.int\/csr\/resources\/publications\/meningitis\/whoemcbac983.pdf."},{"key":"10.1016\/j.vaccine.2008.08.059_bib27","unstructured":"Disease Surveillance Unit, Department of Public Health, Ministry of Health, the Elderly and Community Care, Government of Malta, 2006. Annual Report 2005. Available from: http:\/\/www.health.gov.mt\/dsu\/reports\/index.htm."},{"issue":"April (16)","key":"10.1016\/j.vaccine.2008.08.059_bib28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2008.08.059_bib29","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00006454-200111000-00010","article-title":"Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants","volume":"20","author":"Morley","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"July (10)","key":"10.1016\/j.vaccine.2008.08.059_bib30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0264-410X(96)00001-1","article-title":"Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine","volume":"14","author":"Peeters","year":"1996","journal-title":"Vaccine"},{"issue":"June (20\u201321)","key":"10.1016\/j.vaccine.2008.08.059_bib31","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/S0264-410X(99)00044-4","article-title":"Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins","volume":"17","author":"Cartwright","year":"1999","journal-title":"Vaccine"},{"issue":"February (15)","key":"10.1016\/j.vaccine.2008.08.059_bib32","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0264-410X(99)00423-5","article-title":"Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2\u20133 and 7\u20138 years of age","volume":"18","author":"de Kleijn","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.059_bib33","series-title":"Proceedings of the 14th International Pathogenic Neisseria Conference","first-page":"153","article-title":"From HexaMen to NonaMen: expanding a multivalent PorA-based meningococcal outer membrane vesicle vaccine","author":"Van den Dobbelsteen","year":"2004"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.08.059_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CVI.00230-06","article-title":"Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents","volume":"14","author":"Boutriau","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.059_bib35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/JCM.42.1.320-328.2004","article-title":"Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis","volume":"42","author":"Mothershed","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.08.059_bib36","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1128\/JCM.30.11.2835-2841.1992","article-title":"Identification of meningococcal serosubtypes by polymerase chain reaction","author":"Maiden","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.08.059_bib37","series-title":"26th Annual Meeting of the European Society for Paediatric Infectious Diseases-ESPID","article-title":"A randomized, placebo-controlled, double-blind, phase 1 trial of ascending doses of meningococcal group B rLP2086 vaccine","author":"Nissen","year":"2008"},{"key":"10.1016\/j.vaccine.2008.08.059_bib38","series-title":"15th International Pathogenic Neisseria Conference-IPNC","article-title":"Combination of minor outer membrane proteins inducing bactericidal antibodies in mice","author":"Weynants","year":"2006"},{"issue":"29","key":"10.1016\/j.vaccine.2008.08.059_bib39","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.08.059_bib40","series-title":"26th Annual Meeting of the European Society for Paediatric Infectious Diseases-ESPID","article-title":"Safety and immunogenicity of Novartis meningococcal serogroup B vaccine after three doses administered in infancy","author":"Miller","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T16:57:47Z","timestamp":1631811467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08011894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":40,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0264410X08011894"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}